Herta Launches a New Technology That Allows Facial Identification Even With a Mask

What To Know

  • Herta expects that the impact of this new technology in the market will be very important worldwide and that it will be massively used in environments such as transportation, health, government, events, sports stadiums or in the gaming sector.
  • It is worth noting that the most differential part of the human face is in the eye region.

Based on Deep Learning technology, Herta’s algorithms provide very high identification rates, especially in identity verification tasks and their reliability is very high, even when people hide a large part of their face. It is worth noting that the most differential part of the human face is in the eye region.

The launch of this software is key for automatic passenger identification systems, such as border control with the passport. This way it will not be necessary for the person to remove the mask, avoiding possible contagion or long waiting times. Its application, in general, extends to any type of access control or identity verification system.

Herta expects that the impact of this new technology in the market will be very important worldwide and that it will be massively used in environments such as transportation, health, government, events, sports stadiums or in the gaming sector.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Reeva FT is offered in a variety of sizes: 2x2 cm, 2x3 cm, 4x4 cm, 4x6 cm, 4x8 cm, and 10x15 cm. Reeva FT is confirmed by the FDA Tissue Reference Group to meet the criteria for regulation solely under Section 361 of the PHS Act as defined in 21 CFR Part 1271.
The study is designed to assess the clinical utility and workflow benefits of Swoop® system images acquired at infusion centers and clinics to help physicians detect amyloid-related imaging abnormalities (ARIA) in Alzheimer’s patients receiving amyloid-targeting therapy at the times specified in the labeling (before the fifth, seventh, and fourteenth infusions).
“Tom and I have more than 50 years of experience,” Harp adds. “The decision to found Polymer Medical was done after careful consideration of the landscape and market opportunity; we will raise the level of competition and quality for customers.” Polymer Medical is located in a newly refurbished plant is at 168 Thorn Ave., Orchard Park, N.Y.
The RWE Program will expand Summus Laser's Class IV Laser Therapy research to generate validated and statistically significant datasets that will be used to enhance patient care, outcomes, and to further product innovations.
Details of the session: Polaroid Therapeutics & Avery Dennison Medical: How the power of partnership brings a novel approach to antimicrobial wound dressings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy